Clinical Studies and Defining Inhibitors

Drug Repurposing Studies
Source: Global Health Drug Discovery Institute

The compounds are given as examples and clinical studies are ongoing.

Lopinavir
Lopinavir

Protease inhibitor, anti-HIV approved

Emtricitabine
Emtricitabine

Nucleoside reverse transcriptase inhibitor, anti-HIV approved, anti-HBV

Ritonavir
Ritonavir

Protease inhibitor, anti-HIV approved

Methylprednisolone
Methylprednisolone

nCoV Phase II, approved for allergic asthma and rheumatic diseases